DEVELOPMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPLICATIONS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the field of biopharmaceuticals, giving promising breakthroughs across many healthcare and industrial programs. With its structural similarity to Normally derived human serum albumin, OsrHSA offers a safer, far more trusted choice for therapeutic use, especially in